News

Investing in technology that's a few years from commercialisation can be tricky. Lori Valigra finds out how some venture capitalists sort the wheat from the chaff.

On inventive Californians, technology transfer, how to approach the business press, and other insights into R&D management.

A British pharmaceutical distributor, Beckpharma Ltd., said it licensed two Cuban healthcare products to sell in Europe as part of a broader effort for trade links.

"Scientific work … must be done for itself, for the beauty of science." Marie Curie, chemist & physicist (1867 - 1934)

It has been six years since a French biotech company made a stock market debut – and now two, BioAlliance and ExonHit, are doing so. Is the European market reawakening?

Venture capital’s refusal to continue support helped Cyan Technology into liquidation. Rebuilt by its management, Cyan is now wary of asking VCs for money.

A British start-up is betting it has a better way for television networks to watch their viewers watching them.

OrthoMimetics, the first technology spin-out from the Cambridge-MIT Institute, Cambridge, UK, has begun its search for initial funding.